Adamas Pharmaceuticals
ADMS
#7169
Rank
โ‚ฌ0.34 B
Marketcap
7,48ย โ‚ฌ
Share price
0.00%
Change (1 day)
16,121.73%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.33 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ80.28 Million. In 2020 the company made a revenue of โ‚ฌ67.78 Million an increase over the revenue in the year 2019 that were of โ‚ฌ49.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.33 M9.66%
2020โ‚ฌ67.78 M36.28%
2019โ‚ฌ49.74 M60.48%
2018โ‚ฌ30.99 M
2016โ‚ฌ0.52 M-70.15%
2015โ‚ฌ1.74 M-96.57%
2014โ‚ฌ50.84 M-21.45%
2013โ‚ฌ64.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ74.37 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.60 B 650.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.28 B 63,778.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.58 B 45,461.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ58.41 B 72,661.91%๐Ÿ‡บ๐Ÿ‡ธ USA